Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31097669.
- Also identified by DOI 10.1126/science.aav9406 and PMC identifier 6890515.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The ATP-binding cassette subfamily B member 1 (ABCB1) multidrug transporter P-glycoprotein plays a central role in clearance of xenobiotics in humans and is implicated in cancer resistance to chemotherapy. We used double electron electron resonance spectroscopy to uncover the basis of stimulation of P-glycoprotein adenosine 5'-triphosphate (ATP) hydrolysis by multiple substrates and illuminate how substrates and inhibitors differentially affect its transport function. Our results reveal that substrate-induced acceleration of ATP hydrolysis correlates with stabilization of a high-energy, post-ATP hydrolysis state characterized by structurally asymmetric nucleotide-binding sites. By contrast, this state is destabilized in the substrate-free cycle and by high-affinity inhibitors in favor of structurally symmetric nucleotide binding sites. Together with previous data, our findings lead to a general model of substrate and inhibitor coupling to P-glycoprotein.
Medical subject headings
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors
- ATP Binding Cassette Transporter, Subfamily B/chemistry
- Adenosine Triphosphate
- Adenosine Triphosphate/chemistry
- Adenosine Triphosphate/metabolism
- Allosteric Regulation
- Biological Transport
- Dibenzocycloheptenes
- Dibenzocycloheptenes/chemistry
- Dibenzocycloheptenes/pharmacology
- Electron Spin Resonance Spectroscopy
- Humans
- Hydrolysis
- Models, Chemical
- Protein Structure, Secondary
- Quinolines
- Quinolines/chemistry
- Quinolines/pharmacology